Table 3 Simple and multiple linear regression model (estimated value [95% confidence intervals]) for post index date of pneumonia (post-ID pneumonia) periods in chronic rhinosinusitis with nasal polyp compared to control group and subgroup analysis according to age and sex.

From: Association between chronic rhinosinusitis and pneumonia: a longitudinal follow-up study using a national health screening cohort

Characteristics

Mean ± SD in CRS with nasal polyp group

Mean ± SD in control group

Linear regression of CRS with nasal polyp for pneumonia

Simpleb

P value

Model 1b,c

P value

Model 2b,d

P value

Total participants (n = 16,520)

1-y post-ID pneumonia

0.06 ± 0.44

0.05 ± 0.48

0.011 (− 0.007 to 0.028)

0.240

− 0.008 (− 0.025 to 0.010)

0.398

− 0.004 (− 0.021 to 0.013)

0.653

2-y post-ID pneumonia

0.06 ± 0.45

0.05 ± 0.57

0.013 (− 0.008 to 0.033)

0.232

− 0.004 (− 0.025 to 0.017)

0.710

− 0.001 (− 0.022 to 0.020)

0.920

3-y post-ID pneumonia

0.05 ± 0.47

0.04 ± 0.49

0.009 (− 0.009 to 0.028)

0.336

− 0.004 (− 0.023 to 0.014)

0.643

− 0.003 (− 0.021 to 0.016)

0.786

Age < 60 years old (n = 11,705)

1-y post-ID pneumonia

0.04 ± 0.36

0.03 ± 0.33

0.010 (− 0.005 to 0.026)

0.176

− 0.002 (− 0.017 to 0.014)

0.822

0.002 (− 0.013 to 0.017)

0.811

2-y post-ID pneumonia

0.03 ± 0.30

0.02 ± 0.32

0.009 (− 0.006 to 0.023)

0.234

− 0.003 (− 0.017 to 0.011)

0.674

− 0.001 (− 0.015 to 0.013)

0.910

3-y post-ID pneumonia

0.04 ± 0.43

0.02 ± 0.27

0.021 (0.007 to 0.035)

0.004a

0.012 (− 0.002 to 0.026)

0.104

0.013 (− 0.001 to 0.028)

0.060

Age ≥ 60 years old (n = 4815)

1-y post-ID pneumonia

0.10 ± 0.59

0.09 ± 0.72

0.011 (− 0.037 to 0.058)

0.663

− 0.014 (− 0.062 to 0.034)

0.566

− 0.010 (− 0.057 to 0.037)

0.675

2-y post-ID pneumonia

0.12 ± 0.68

0.10 ± 0.92

0.022 (− 0.040 to 0.084)

0.484

0.002 (− 0.060 to 0.064)

0.939

0.006 (− 0.055 to 0.068)

0.843

3-y post-ID pneumonia

0.07 ± 0.55

0.09 ± 0.81

− 0.019 (− 0.073 to 0.035)

0.490

− 0.036 (− 0.090 to 0.018)

0.192

− 0.034 (− 0.088 to 0.020)

0.217

Males (n = 10,880)

1-y post-ID pneumonia

0.05 ± 0.42

0.05 ± 0.52

0.005 (− 0.018 to 0.028)

0.659

− 0.013 (− 0.036 to 0.010)

0.282

− 0.010 (− 0.033 to 0.013)

0.391

2-y post-ID pneumonia

0.06 ± 0.47

0.05 ± 0.58

0.015 (− 0.011 to 0.041)

0.254

− 0.002 (− 0.028 to 0.024)

0.884

0.000 (− 0.026 to 0.026)

0.998

3-y post-ID pneumonia

0.05 ± 0.46

0.05 ± 0.55

0.002 (− 0.023 to 0.027)

0.869

− 0.012 (− 0.037 to 0.013)

0.348

− 0.010 (− 0.035 to 0.014)

0.413

Females (n = 5640)

1-y post-ID pneumonia

0.06 ± 0.48

0.04 ± 0.38

0.021 (− 0.005 to 0.047)

0.118

0.003 (− 0.023 to 0.030)

0.798

0.009 (− 0.017 to 0.035)

0.493

2-y post-ID pneumonia

0.05 ± 0.39

0.04 ± 0.55

0.008 (− 0.026 to 0.042)

0.654

− 0.010 (− 0.044 to 0.024)

0.566

− 0.005 (− 0.039 to 0.029)

0.772

3-y post-ID pneumonia

0.06 ± 0.50

0.04 ± 0.37

0.023 (− 0.003 to 0.049)

0.088

0.010 (− 0.016 to 0.036)

0.449

0.012 (− 0.014 to 0.039)

0.355

  1. Abbreviations: CCI, Charlson comorbidity index; COPD, chronic obstructive pulmonary disease; DBP, diastolic blood pressure; CRS, chronic rhinosinusitis; 1-y pre-ID pneumonia, pneumonia history from the date of CRS treatment (index date) to the date before 1-year periods; Post-ID pneumonia, the number of pneumonia diagnosis from the index date to the date after certain periods; SBP, systolic blood pressure; SD, standard deviation.
  2. aLinear regression model, Significance at P < 0.05.
  3. bModels were stratified by age, sex, income, and region of residence.
  4. cA model 1 was adjusted for obesity, smoking, alcohol consumption, total cholesterol, SBP, DBP, fasting blood glucose, CCI scores, asthma, and COPD.
  5. dA model 2 was adjusted for the model 1 plus 1-y pre-ID pneumonia.